Skip to content
2000
Volume 17, Issue 3
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Small interfering RNA (siRNA) has been demonstrated to be a powerful tool for silencing post-transcriptional gene expression, and thus exhibits great potential in cancer gene therapy. However, siRNA technology has not become an established strategy for cancer treatment, as it is a considerable challenge to deliver siRNA to the targeting sites. In this review, barricades in the systemic delivery of siRNA were systematically introduced, from pharmacokinetics, biodistribution and intracellular behavior. Meanwhile, current and potential strategies for overcoming the barricades were elucidated, including chemical modification of siRNA, nanomaterial-based delivery systems, and targeting and stimuli-responsive smart carriers. In conclusion, the siRNA-based gene silencing drug will gain an important position for treating human diseases if we can solve the gap between ideal and reality.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201017666151029110710
2016-03-01
2025-06-30
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201017666151029110710
Loading

  • Article Type:
    Research Article
Keyword(s): barricade; delivery system; gene silencing; siRNA; smart carrier
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test